Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Dr. Sorror is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
Assiut University Faculty of MedicineClass of 1994
Certifications & Licensure
MT State Medical License 2022 - 2026
WA State Medical License 2010 - 2026
Clinical Trials
- Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2004 Dec 01
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Start of enrollment: 2010 Mar 18
- Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704.Mohamed L Sorror, Wael Saber, Brent R Logan, Nancy L Geller, Anna Bellach
Blood Advances. 2025-03-18 - Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.Natalie Wuliji, Salene M W Jones, Ted A Gooley, Aaron T Gerds, Bruno C Medeiros
Blood. 2025-03-11 - US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for T...Pashna N Munshi, Rebecca L Olin, Sarah Wall, Shannon R McCurdy, Taha Al-Juhaishi
Transplantation and Cellular Therapy. 2025-02-15
Journal Articles
- Pre-Transplant Expressions of microRNAs, Comorbidities, and Post-Transplant MortalityMohamed L Sorror, Muneesh Tewari, Nature
Press Mentions
Multi-Center Study Shows Education Level, Income Impact Access to Stem Cell Transplantation for Acute Myeloid Leukemia PatientsDecember 8th, 2024
Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018
Age No Longer a Barrier to Stem Cell Transplantation for Older PatientsNovember 2nd, 2011- Join now to see all
Grant Support
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2011–2012
- Impact Of Comorbidities On Outcomes Of Allogeneic TransplantationNational Heart, Lung, And Blood Institute2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
